Milbemycin oxime
CAS No. 129496-10-2
Milbemycin oxime ( CGA179246 | Milbemycin A 5-oxime | Milbemite | Trifexis )
产品货号. M11192 CAS No. 129496-10-2
Milbemycin oxime 是一种大环内酯,具有广谱抗寄生虫活性。Milbemycin oxime 由 Milbemycin A4 和 A3 组成。Milbemycin oxime 可以结合谷氨酸门控的氯离子通道。Milbemycin oxime 可作用于肠道线虫,肺和心脏蠕虫。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ¥469 | 有现货 |
|
| 50MG | ¥1021 | 有现货 |
|
| 100MG | ¥1432 | 有现货 |
|
| 200MG | ¥1961 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥567 | 有现货 |
|
生物学信息
-
产品名称Milbemycin oxime
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Milbemycin oxime 是一种大环内酯,具有广谱抗寄生虫活性。Milbemycin oxime 由 Milbemycin A4 和 A3 组成。Milbemycin oxime 可以结合谷氨酸门控的氯离子通道。Milbemycin oxime 可作用于肠道线虫,肺和心脏蠕虫。
-
产品描述Milbemycin oxime is a veterinary drug from the group of milbemycins, used as a broad spectrum antiparasitic.
-
体外实验——
-
体内实验——
-
同义词CGA179246 | Milbemycin A 5-oxime | Milbemite | Trifexis
-
通路Others
-
靶点Other Targets
-
受体Antiparasitic
-
研究领域Infection
-
适应症——
化学信息
-
CAS Number129496-10-2
-
分子量1097.38
-
分子式C63H88N2O14
-
纯度>98% (HPLC)
-
溶解度DMSO: 10 mM
-
SMILESCC[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/C[C@H](/C=C/C=C/4\CO[C@H]\5[C@@]4([C@@H](C=C(/C5=N/O)C)C(=O)O3)O)C)\C)C.C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/C[C@H](/C=C/C=C/4\CO[C@H]\5[C@@]4([C@@H](C=C(/C5=N/O)C)C(=O)O3)O)C)\C)O[C@@H]1C
-
化学全称None (it is a mixture of two molecules)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
WAY-100635 Maleate
WAY-100635 是一种特异性有效的 5-HT 受体拮抗剂 (IC50=0.95 nM)。
-
N-[2-nitro-4-(triflu...
N-[2-nitro-4-(trifluoromethyl)phenyl]piperazine is a biologically active compound belonging to the piperazine group. It is an important synthetic intermediate used in the preparation of a wide range of drugs, agrochemicals and other chemicals. It is considered an inhibitor of certain enzymes involved in drug metabolism, such as cytochrome P450 enzymes, and has also been shown to have anti-inflammatory and antitumor effects.
-
Ac2-26 TFA
Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.
021-51111890
购物车()
sales@molnova.cn

